BioUtah, the trade association representing Utah's life sciences community, will participate in the J.P. Morgan 44th Annual Healthcare Conference from January 11-16, 2026, in San Francisco. BioUtah President and CEO Kelvyn Cullimore will attend on behalf of the association, representing more than 1,600 life sciences companies across Utah. The state's industry strengths include medical device manufacturing, diagnostics, biotechnology, pharmaceuticals, and digital health.
The J.P. Morgan Healthcare Conference represents one of the most significant annual gatherings in the global healthcare investment community, attracting thousands of executives, investors, and industry leaders. BioUtah's presence at this event signals Utah's growing prominence in the life sciences sector and provides valuable networking opportunities for the state's companies. As the common voice for Utah's life sciences community, BioUtah's participation helps elevate the profile of the state's industry on an international stage.
During the conference, BioUtah will co-host a state bio reception on Sunday night, January 11, 2026. This event offers additional networking opportunities for Utah companies attending the conference and helps strengthen connections within the state's life sciences ecosystem. The reception represents a strategic opportunity for Utah companies to connect with potential investors, partners, and collaborators in an informal setting.
Following the J.P. Morgan conference, BioUtah will host the 2026 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit in Salt Lake City on March 12-13, 2026. The event includes a Snowbird ski day, and early bird registration is currently open. This summit provides another platform for Utah's life sciences companies to engage with entrepreneurs and investors focused on the healthcare sector. More information about BioUtah's activities and events can be found at https://bioutah.org.
BioUtah's participation in these high-profile events reflects the growing economic importance of Utah's life sciences industry. The sector serves as a key driver of Utah's economy while advancing healthcare innovation nationally and globally. Utah's strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and diagnostics position the state as a significant contributor to healthcare advancement. BioUtah's representation at the J.P. Morgan conference helps ensure Utah's life sciences community maintains visibility among key decision-makers and investors in the healthcare industry.
The implications of BioUtah's conference participation extend beyond immediate networking opportunities. Increased visibility at such events can attract investment to Utah's life sciences companies, foster partnerships that accelerate innovation, and enhance the state's reputation as a hub for healthcare technology development. For Utah companies, this representation provides access to global markets and potential collaborators that might otherwise be difficult to reach. The life sciences industry's growth in Utah contributes to job creation, economic diversification, and healthcare advancements that benefit patients worldwide.
